Stay updated on BMS-986016 Safety Study with or without Nivolumab Clinical Trial
Sign up to get notified when there's something new on the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page.

Latest updates to the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no trial content or core details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Locations section with Chiba, Japan; removed HHS Vulnerability Disclosure and Chiba Locations, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page revision history shows an addition of Revision: v3.3.2 and removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe government funding operating-status notice was removed from the page; core study details and eligibility information remain unchanged.SummaryDifference0.4%

- Check73 days agoChange DetectedUpdated study record dates and the last update timestamp (e.g., Last Update Posted 2025-02-17) are visible, while the primary study details and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check102 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference5%

Stay in the know with updates to BMS-986016 Safety Study with or without Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page.